On this page you’ll find important information about possible therapies for your ENT tumour with the aid of proton therapy (PT) at the WPE. This pinpoint-accurate and therefore cautious form of radiotherapy enables the treatment of many benign and malignant ENT and head and neck tumours. At the present time we are treating predominantly advanced head and neck tumours, e.g. nasopharynx cancer (tumours in the nasal pharynx), cancer of the paranasal sinuses, esthesioneuroblastomas and cancer of the salivary gland. The therapy options and the course of therapy at our centre are always oriented to the individual clinical picture of each patient
Our Case Management staff will be pleased to advise you personally in all questions and control the therapy at the WPE. In addition, they help you with the compilation of the required documentation and direct you to a radiotherapy specialist. Please contact us even in the event that the ENT tumour relevant for you is not listed here – we examine each individual case in detail.
Even if proton therapy is not the optimum form of treatment we will be pleased to suggest contact partners for you at the West German Tumour Centre (WTZ), with which the WPE is affiliated.
As a rule, an ENT tumour can be treated with proton therapy provided that your attending medical specialist or oncologist has recommended radiotherapy. However, as your particular clinical picture is decisive, our radio-oncologists examine your personal situation down to the last medical detail.
Every patient and every ENT tumour is different. Consequently, we always advise our patients individually. Your way to us is via our Case Management. This is the interface between you and our medical and therapy team. Following your enquiry or an enquiry of your family or doctor, a personal member of the Case Management team is assigned to you from the beginning of your therapy and provides support with the compilation of the required documentation. When the complete documentation has been submitted, a radio-oncologist examines these.